| SN. |
Smith & Nephew
|
FTSE 100 |
2.34 |
£10.64B |
1,205.50 |
-3.68% |
| CTEC |
ConvaTec Group
|
FTSE 100 |
2.32 |
£4.57B |
223.60 |
-4.36% |
| UPR |
Uniphar
|
AIM |
0.00 |
£885.94M |
335.11 |
0.90% |
| SPI |
Spire Healthcare Group
|
FTSE 250 |
0.81 |
£761.22M |
178.00 |
-5.82% |
| AMS |
Advanced Medical Solutions Group
|
AIM |
1.37 |
£423.38M |
201.00 |
3.10% |
| NIOX |
Niox Group
|
AIM |
2.13 |
£244.91M |
58.00 |
% |
| TSTL |
Tristel
|
AIM |
3.66 |
£185.73M |
380.00 |
1.60% |
| EKF |
EKF Diagnostics Holdings
|
AIM |
|
£105.31M |
24.30 |
1.00% |
| SPEC |
Inspecs Group
|
AIM |
|
£84.39M |
83.01 |
-0.30% |
| SDI |
SDI Group
|
AIM |
|
£74.02M |
68.00 |
-1.50% |
| KMK |
Kromek Group
|
AIM |
|
£65.51M |
9.95 |
8.70% |
| CREO |
Creo Medical Group
|
AIM |
|
£53.83M |
12.13 |
-0.80% |
| NCYT |
Novacyt SA
|
AIM |
|
£23.49M |
33.90 |
4.20% |
| IHC |
Inspiration Healthcare Group
|
AIM |
|
£21.52M |
23.80 |
0.60% |
| COG |
Cambridge Cognition Holdings
|
AIM |
|
£16.54M |
37.00 |
-0.40% |
| FAB |
Fusion Antibodies
|
AIM |
|
£15.63M |
11.51 |
25.90% |
| RUA |
RUA Life Sciences
|
AIM |
|
£8.84M |
13.65 |
-6.90% |
| GENI |
Genincode
|
AIM |
|
£8.1M |
1.05 |
1.40% |
| MHC |
MyHealthChecked
|
AIM |
|
£4.55M |
8.75 |
5.30% |
| SUN |
Surgical Innovations Group
|
AIM |
|
£4.2M |
0.50 |
-2.30% |
| BELL |
Belluscura
|
AIM |
|
£3.01M |
0.75 |
-1.10% |
| PYC |
Physiomics
|
AIM |
|
£1.81M |
0.40 |
-3.80% |
| TLY |
Totally
|
AIM |
|
– |
0.24 |
-1.90% |
| POLX |
Polarean Imaging
|
AIM |
|
– |
0.08 |
-3.20% |
| TRLS |
Trellus Health
|
AIM |
|
– |
0.30 |
7.30% |